Introduction to Refractory Cardiogenic
Sentence Examples
Discover more insights into Refractory Cardiogenic
Keywords frequently search together with Refractory Cardiogenic
Narrow sentence examples with built-in keyword filters
Refractory Cardiogenic sentence examples within veno arterial extracorporeal
Emergent veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly used to provide rapid cardiopulmonary resuscitation in adult patients with refractory cardiogenic shock.
Full Text
Background
Refractory cardiogenic shock (CS), frequently complicated by pulmonary failure, often requires veno-arterial extracorporeal membrane oxygenation (VA-ECMO) to sustain end-organ perfusion.
Full Text
Refractory Cardiogenic sentence examples within venoarterial extracorporeal membrane
He was ultimately treated with venoarterial extracorporeal membrane oxygenation (VA-ECMO) for refractory cardiogenic shock which enabled him to recover normal left ventricular function while his thyroid hormone levels normalized.
Full Text
BACKGROUND
Venoarterial-extracorporeal membrane oxygenation (VA-ECMO) is currently one of the first-line therapies for refractory cardiogenic shock (CS), but its applicability is undermined by the high morbidity associated with its complications, especially those related to mechanical ventilation (MV).
Full Text
Refractory Cardiogenic sentence examples within mechanical circulatory support
68 patients with refractory cardiogenic shock without mechanical circulatory support were matched with 68 patients treated with Impella CP.
Full Text
Despite early coronary revascularization and conventional support, refractory cardiogenic shock ensued requiring mechanical circulatory support escalation to Veno-arterial extracorporeal membrane oxygenation.
Full Text
Learn more from Refractory Cardiogenic
Refractory Cardiogenic sentence examples within extracorporeal membrane oxygenation
OBJECTIVES
The aim of this study was to investigate whether earlier extracorporeal membrane oxygenation (ECMO) support is associated with improved clinical outcomes in patients with refractory cardiogenic shock (CS).
Full Text
Optimal medical treatment allows for safe management of most of these cardiovascular presentations while COVID‐19‐associated refractory cardiogenic shock could be rescued by veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO).
Full Text
Refractory Cardiogenic sentence examples within end organ perfusion
Compared with full flow VA ECMO, partial flow VA ECMO in carefully selected patients results in similar in-hospital mortality and provides similar end-organ perfusion for the treatment of refractory cardiogenic shock.
Full Text
Refractory Cardiogenic sentence examples within ventricular assist device
Lack of myocardial recovery or therapy‐refractory cardiogenic shock are rare complications and left ventricular assist device (LVAD) systems might be used as a life‐saving option.
Full Text
Refractory Cardiogenic sentence examples within Developed Refractory Cardiogenic
Refractory Cardiogenic sentence examples within Treat Refractory Cardiogenic
BACKGROUND
Veno-arterial extracorporeal life support (VA-ECLS) is widely used to treat refractory cardiogenic shock.
Full Text
Background Use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) in adult patients to treat refractory cardiogenic shock has increased in recent years, and ischemic stroke is the most frequent VA-ECMO-induced cerebrovascular complication.
Full Text
Refractory Cardiogenic sentence examples within refractory cardiogenic shock
CASE REPORT
This report concerns a case of refractory cardiogenic shock due to acute myocarditis in a 35-year-old puerperal female patient who presented with retrosternal pain, fatigue and dyspnea.
Full Text
He was ultimately treated with venoarterial extracorporeal membrane oxygenation (VA-ECMO) for refractory cardiogenic shock which enabled him to recover normal left ventricular function while his thyroid hormone levels normalized.
Full Text
CASE REPORT
This report concerns a case of refractory cardiogenic shock due to acute myocarditis in a 35-year-old puerperal female patient who presented with retrosternal pain, fatigue and dyspnea.
Full Text
Methods This is a retrospective review of 33 patients with refractory cardiogenic shock requiring VA ECMO who underwent surgical LV vent placement between July 2015 and March 2020.
Full Text
6%) had refractory cardiogenic shock, 7 patients (11.
Full Text
Indications We suggest VA ECMO be considered for poisoned patients with refractory cardiogenic shock (continued shock with myocardial dysfunction despite fluid resuscitation, vasoactive support, and indicated toxicologic therapies such as glucagon, intravenous lipid emulsion, hyperinsulinemia euglycemia therapy, or others), and strongly considered for patients with cardiac arrest in institutions which are structured to deliver effective ECPR.
Full Text
This review discusses the preferred approaches, cannulation techniques, and available support devices ideal for the various clinical situations encountered during the treatment of cardiac arrest and refractory cardiogenic shock.
Full Text
Results Thirty-five patients were admitted because of refractory cardiogenic shock (26 of 35 survived) and the remaining 36 patients due to cardiac arrest (13 of 36 survived).
Full Text
RESULTS
114 veino-arterial ECMOs were implanted for refractory cardiogenic shock after 5702 cardiac surgeries (1.
Full Text
All consecutive patients who underwent peripheral femoro-femoral VA-ECMO percutaneous implantation for refractory cardiogenic shock or cardiac arrest were enrolled in a prospective registry (03/2018–12/2020).
Full Text
Acute myocardial infarction with refractory cardiogenic shock (AMI-RCS) is associated with poor outcomes.
Full Text
Studies that included post-cardiotomy, septic shock, respiratory failure or refractory cardiogenic shock were excluded.
Full Text
Methods: This retrospective single-center study included 265 adults supported by VA-ECMO for refractory cardiogenic shock from January 2015 to June 2019.
Full Text
The study included 65 adult patients supported with femoral VA-ECMO for refractory cardiogenic shock.
Full Text
Veno-arterial membrane oxygenation (VA-ECMO) can be used as a rescue therapy for patients in refractory cardiogenic shock.
Full Text
In our patient, cardiac catheterization which was performed during his hospitalization confirmed no ischemic disease and suggested the presence of myocarditis which was ultimately fatal in the setting of refractory cardiogenic shock.
Full Text
Treatment of refractory cardiogenic shock has poor outcome.
Full Text
Discussion: The addition of LV Impella and RV support by Impella (BiPELLA) on top of VA-ECMO may support survival of patients with refractory cardiogenic shock.
Full Text
The 3rd case is a 45-year-old patient carrying a dilated cardiomyopathy with severe biventricular dysfunction and multivisceral failure who benefited from a VA ECMO for a refractory cardiogenic shock as a “bridge to heart transplant”.
Full Text
A subset of these advanced HF patients deteriorates into refractory cardiogenic shock, that is challenging to manage with vasoactive agents alone.
Full Text
All consecutive patients who underwent peripheral femoro-femoral VA-ECMO percutaneous implantation for refractory cardiogenic shock or cardiac arrest were enrolled in a prospective registry (03/2018-09/2020).
Full Text
Discussion Pheochromocytoma crisis turned into a potential catastrophic scenario, characterized by refractory cardiogenic shock requiring circulatory supportive devices and PRES.
Full Text
We report the case of a 69-year-old man suffering from a refractory cardiogenic shock, without significant lung involvement.
Full Text
She was transferred to a tertiary care center in refractory cardiogenic shock for ECMO evaluation.
Full Text
The Swan-Ganz monitoring was not consistent with the refractory cardiogenic shock following hepatopathy.
Full Text
Subsequently, she progressed to refractory cardiogenic shock necessitating four vasopressor agents.
Full Text
However, due to refractory cardiogenic shock, peripheral veno-arterial extra-corporeal membrane oxygenation (VA-ECMO) was instituted immediately via right common femoral cannulation: 25F venous, 17F arterial, and 6F distal arterial reperfusion.
Full Text
The indications were refractory hypoxaemic respiratory failure in 9, tracheo-oesophageal fistula and respiratory failure in 1, support during surgery for planned tracheal reconstruction in 1, and refractory cardiogenic shock in 3 patients.
Full Text
Severe acute respiratory distress syndrome (ARDS) and/or refractory cardiogenic shock or cardiac arrest caused by toxins are associated with high mortality and are difficult to treat.
Full Text
5 to improve native heart function in refractory cardiogenic shock and further indicate its use as an option for those in acute decompensated heart failure who have tested positive for COVID-19 infection.
Full Text
Due to refractory cardiogenic shock and prohibitive cardiac surgical risk, weight-based intravenous tenecteplase was administered emergently.
Full Text
An emerging therapeutic modality, ECPELLA, which combines a transvalvular microaxial left ventricular (LV) assist device, Impella, and venoarterial membrane oxygenation (VA‐ECMO), has been applied for patients with refractory cardiogenic shock.
Full Text
Conclusion Complete percutaneous angio-guided VA-ECMO implantation and decannulation using pre-closing technique is an effective and safe strategy in patients referred for refractory cardiogenic shock or cardiac arrest.
Full Text
The second case is a refractory cardiogenic shock due to left main stent thrombosis myocardial infarction.
Full Text
Case Report 58-year-old gentleman with long-standing NICM, LV EF 20-25%, atrial fibrillation (AF), CKD stage III, recent COVID-19, presented with an ST elevation myocardial infarction and progressed to refractory cardiogenic shock.
Full Text
Purpose Veno-arterial (VA) ECMO plays a central role in patients with refractory cardiogenic shock.
Full Text
Introduction Patients with refractory cardiogenic shock have a mortality in excess of 80%.
Full Text
BackgroundExtracorporeal membrane oxygenation offers temporary hemodynamic support for patients with refractory cardiogenic shock after cardiovascular surgery.
Full Text
This chapter summarizes the key points for clinicians regarding the specific management of patients with refractory acute respiratory distress syndrome on venovenous ECMO and those with refractory cardiogenic shock supported by venoarterial ECMO.
Full Text
The patient evolved to refractory cardiogenic shock despite the clinical measures applied.
Full Text
Purpose To investigate the outcome of patients in refractory cardiogenic shock who required VA ECMO as a bridge to durable LVAD Methods This is a retrospective review of all adult INTERMACS profile 1 patients who underwent LVAD implantation at our institution between 01/01/2015 and 12/31/2017.
Full Text
This patient required support with a TandemHeart percutaneous ventricular assist device for refractory cardiogenic shock, followed by a durable ventricular assist device, and ultimately a heart transplant.
Full Text
RESULTS
Predictors of neurological complications were refractory cardiogenic shock following cardiotomy (OR = 0.
Full Text
Refractory cardiogenic shock (RCS) is associated with a high mortality.
Full Text
Peripheral veno-arterial membrane oxygenation (PVA-ECMO) is increasingly used as first-line therapy during refractory cardiogenic shock.
Full Text
CONCLUSIONS
The ECMO-ACCEPTS score might help clinicians to improve risk prediction among VA-ECMO patients for refractory cardiogenic shock.
Full Text
ECMO has been available for four decades and has gained use as a rescue therapy in severe refractory hypoxic disorders and in patients with refractory cardiogenic shock (RCS).
Full Text
In 48 hours, he progressed to refractory cardiogenic shock and multiorgan failure with oliguria, coagulopathy, and mild cognitive impairment.
Full Text
ConclusionsThe REMEMBER score might help clinicians at bedside to predict in-hospital mortality for patients receiving VA-ECMO after isolated CABG for refractory cardiogenic shock.
Full Text
0 micro-axial flow device has been increasingly used in refractory cardiogenic shock as a bridge to; long-term therapy or recovery.
Full Text
We conducted a retrospective review of patients who received EC-VAD (n = 29) or isolated VA-ECMO therapy (ECMO-only; n = 196) for refractory cardiogenic shock between February 2011 and October 2014.
Full Text
However, she went into refractory cardiogenic shock and did not survive.
Full Text
Background
Despite advances in management techniques and medical therapy, refractory cardiogenic shock remains a life-threatening condition with high mortality rates.
Full Text
Purpose ECMO for the treatment of refractory cardiogenic shock (RCS) has demonstrated dubious results after 9 days of support.
Full Text
Development of therapy‐refractory cardiogenic shock is described in the literature with a limited number of overall presented cases in this young patient cohort.
Full Text
All patients in whom ECMO was initiated due to refractory cardiogenic shock between 2009 and 2014 were included in the study.
Full Text
ECMO provides a good temporary cardiopulmonary support in STAAD patients with refractory cardiogenic shock after surgery for aortic dissection.
Full Text